O. Merimsky et al., AMPUTATION OF THE LOWER-LIMB AS PALLIATIVE TREATMENT FOR DEBILITATINGMUSCULOSKELETAL CANCER, Oncology Reports, 4(5), 1997, pp. 1059-1062
Limb sparing surgery has replaced amputation surgery for treating sarc
omas of the lower limb in most cases. Wide resection followed by posto
perative radiation therapy can achieve acceptable local control and su
rvival rates in patients with bone and soft-tissue sarcomas of the low
er limb. Recurrent or persistent disease constitutes a major oncologic
al problem. Local symptoms such as agonizing pain, fractures, tumor fu
ngation, inability to walk and inability to maintain daily activities,
further impair the patient's quality of life. In this clinical set-up
palliative amputation of the limb should be considered. Fourteen pati
ents with soft-tissue or bone sarcomas underwent palliative major ampu
tation. The procedures included: hemipelvectomy, hip disarticulation,
knee disarticulation, above or below-knee amputation. Local control of
the disease and pain, and improvement of the performance status were
observed in 13 evaluable patients. The mobility was restored in 13/14
patients. The median survival following the procedure was 9 months. Th
ere was only one case of immediate post-operative death. Severe phanto
m pain was not reported by any of the patients. Quality of life was re
ported to be improved by two-thirds of the patients. We found palliati
ve major amputation surgery worth-performing in low-performance status
cancer patients with locally advanced disease of the lower limb.